Nature Communications (Jul 2023)

Engineered reporter phages for detection of Escherichia coli, Enterococcus, and Klebsiella in urine

  • Susanne Meile,
  • Jiemin Du,
  • Samuel Staubli,
  • Sebastian Grossmann,
  • Hendrik Koliwer-Brandl,
  • Pietro Piffaretti,
  • Lorenz Leitner,
  • Cassandra I. Matter,
  • Jasmin Baggenstos,
  • Laura Hunold,
  • Sonja Milek,
  • Christian Guebeli,
  • Marko Kozomara-Hocke,
  • Vera Neumeier,
  • Angela Botteon,
  • Jochen Klumpp,
  • Jonas Marschall,
  • Shawna McCallin,
  • Reinhard Zbinden,
  • Thomas M. Kessler,
  • Martin J. Loessner,
  • Matthew Dunne,
  • Samuel Kilcher

DOI
https://doi.org/10.1038/s41467-023-39863-x
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 15

Abstract

Read online

Abstract The rapid detection and species-level differentiation of bacterial pathogens facilitates antibiotic stewardship and improves disease management. Here, we develop a rapid bacteriophage-based diagnostic assay to detect the most prevalent pathogens causing urinary tract infections: Escherichia coli, Enterococcus spp., and Klebsiella spp. For each uropathogen, two virulent phages were genetically engineered to express a nanoluciferase reporter gene upon host infection. Using 206 patient urine samples, reporter phage-induced bioluminescence was quantified to identify bacteriuria and the assay was benchmarked against conventional urinalysis. Overall, E. coli, Enterococcus spp., and Klebsiella spp. were each detected with high sensitivity (68%, 78%, 87%), specificity (99%, 99%, 99%), and accuracy (90%, 94%, 98%) at a resolution of ≥103 CFU/ml within 5 h. We further demonstrate how bioluminescence in urine can be used to predict phage antibacterial activity, demonstrating the future potential of reporter phages as companion diagnostics that guide patient-phage matching prior to therapeutic phage application.